Stay informed with the latest updates for the inheritable blood disorders community.

Medical
Hemophilia History the Focus of New Partners Modules
Hemophilia History the Focus of New Partners Modules
COVID-19
COVID-19 Assistance Programs
COVID-19 Assistance Programs
Industry
BioMarin Releases Trial Updates in Lead Up to WFH Virtual Summit
BioMarin Releases Trial Updates in Lead Up to WFH Virtual Summit
NBDF & Community
We Stand With You
We Stand With You
COVID-19
COVID-19 Webinars and Newsletter Update
COVID-19 Webinars and Newsletter Update
COVID-19
Town Hall Webinar - Inhibitors: Coping During COVID-19
Town Hall Webinar - Inhibitors: Coping During COVID-19
Medical
Accredited Gene Therapy Educational Opportunities Available Online Now
Accredited Gene Therapy Educational Opportunities Available Online Now
Peer-Reviewed Journal Summaries
Establishing a New Paradigm to Realize Health Equity in Hemophilia
Establishing a New Paradigm to Realize Health Equity in Hemophilia
COVID-19
Town Hall Webinar - Playing It Safe: Coping During COVID-19
Town Hall Webinar - Playing It Safe: Coping During COVID-19
COVID-19
Genentech Provides Updates on Hemlibra Product Particles
Statement from Novo Nordisk on Rebinyn and COVID-19
COVID-19
Health and Wellness Update #9 from Dr. Valentino
Health and Wellness Update #9 from Dr. Valentino
NBDF & Community
NHF's Board of Directors Meeting
NHF's May 2020 Board of Directors Meeting
COVID-19
Letter to the NHF Community
Letter to the NHF Community
Medical
Investigators Look at Hematuria as Hypertension Risk Factor in Hemophilia Patients
Investigators Look at Hematuria as Hypertension Risk Factor in…
COVID-19
BDC 2020 Updates and Transition to Virtual
BDC 2020 Updates and Transition to Virtual